Insider Own 62.93%

epigenetics first mover with NVO deal and flagship backed..... lots of shares sold short.
See the indications listed in their presentation -- then "undisclosed" target gene partnered with Novo Nordisk for obesity -- They must have seen something they liked?

a lot of momentum here..... I believe too much.
Sitting at 400m market cap, ~1 quarter left in cash and 150m operating expense per year

running towards two readouts with Gilead sitting at 17% ownership at 1.97$ strike. I have the hubris to say this WILL GO GO

LLY participate in offering on top of 3.5bn deal... at 3.50 strike
i believe 5$ next

https://www.globenewswire.com/news-release/2024/10/23/2967435/33039/en/ProQR-Prices-75-Million-Underwritten-Public-Offering-and-Concurrent-Private-Placement.html

TLSA for progressive MS
smart and genuine CEO in good "company"
https://en.wikipedia.org/wiki/Howard_L._Weiner
https://finance.yahoo.com/news/tiziana-life-sciences-announces-live-110000183.html

super action............ to the finish line

maybe they will release the data on the 10q. Would be a nice opportunity to follow up on future funding given they canceled their atm offering in the summer.
They delayed this readout for so long, coupled with sheer optimism in their replies. I think they will want to include some patients that continued to live for very long.... I believe more people think similar as we had these sudden bursts higher in recent weeks. If the data was bad, the readout wouldve been released by now and they wouldve kept their ATM around.

They know no one believes in multi target antigens. If they let the data speak a true verdict -- the funding wont be an issue. I actually believe a partner is coming.

ELDN 5.50
PRQR 3.63

VSTE wowser... it has THAT look

I love the CEO - was at Flagship and Chief Immunology Officer at GSK. Parachuted in to finish the job.

The panc data was the best i have ever seen.... You rarely read about such a 36 month surival here. 47% -- atleast the rest of the market was equally surprised their appoach works.
Eventually CAN3110 will be used in all cancers that express nectin

CDXC is the leader in NAD+ research and already sells a product. NAD+ helps energy uptake in the cell and DNA repair. In my opinion the only anti aging compound thats not snake oil.
But the management is apathic and loves to sell shares to the public so things are slow.

Breaking news for CAN-3110 in recurrent glioblastoma): ongoing survival > 12 months after repeated administration of CAN-3110 in half of the patients with brain tumor despite previous neurosurgical resection, chemotherapy, and radiotherapy. $CADL
https://t.co/LU4QEq4XFf

— Dr. Paul Peter Tak (@paulpetertak) October 28, 2024

ELDN 5$

Dear Laster, sadly I am usually inactive on individual boards because rarely someone replies. I agree with all that you said. Great things happening here. Hoping for 7$. I believe the T1D can help it further.

ELDN 4.65 in motion --- think 7$ coming........... daily chart: https://schrts.co/CeeftANt
organ transplant - shared some more on the board for those interested

these have worked out for me.
this might fix T1D. Great work with CareDX

VOR .81 some volume around this bottom
super science - helps AML patients tolerate more of the medicine that heals.

IONQ 15.50 recover
KSCP 19

ELDN 4.45

IONQ 15.12 reverse
ROOT wowser....

KSCP 19.24...

ADMA 17......... now moving back to 20$

CRDF 3.33....

XLO 1.33 running towards data presentation Nov8...

MGTX 6.03 https://schrts.co/pzWyubSC

ENSC has many shots on goal and is still an infant. LYRA failed already and looks like a money grab now -- Just a heads up - wont bet against Perceptive.

STI no clue sadly... not familiar with batteries.

LYRA they try the same product (very close to SOC) in nearly the same indication they failed their other ph3 with so i thought its to sell more shares-------------- BUT Perceptive bought ~.29 so what do i know

COMING TO LIFE
masked antibodies

KSCP 17.78...........

super idea!

IONQ 16

super dip opp

GRRR 4.35
https://schrts.co/pwmdGaMX

CRDF 3.12 https://schrts.co/DmmwcdmS
is Pfizer partner and running towards ph2 readout scheduled in H2 24

CRDF 3.13

UPWK 13.24 breakout pattern

PRQR 3.67 +.36 in the pm

ATYR 3.51 +.19 in the pm

Dear Mick, i trade every session but currently dont have a position in ASNS. I wait for a sign

Check out their recent presentation- wants to get the word out there -- smart management i believe.......... genuine? i dont know
https://ir.actelis.com/company-information/presentations